The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
03 2021
Historique:
received: 17 02 2020
accepted: 16 09 2020
pubmed: 10 10 2020
medline: 3 7 2021
entrez: 9 10 2020
Statut: epublish

Résumé

Bronchiolitis obliterans syndrome (BOS) is a fibrotic disease that is heavily responsible for the high mortality rates after lung transplantation. Myofibroblasts are primary effectors of this fibrotic process, but their origin is still debated. The purpose of this work was to identify the precursors of mesenchymal cells responsible for post-transplant airway fibro-obliteration.Lineage-tracing tools were used to track or deplete potential sources of myofibroblasts in the heterotopic tracheal transplantation model. Allografts were analysed by histology, confocal microscopy, flow cytometry or single-cell transcriptomic analysis. BOS explants were evaluated by histology and confocal microscopy.Myofibroblasts in the allografts were recipient-derived. When recipient mice were treated with tacrolimus, we observed rare epithelial-to-mesenchymal transition phenomena and an overall increase in donor-derived myofibroblasts (p=0.0467), but the proportion of these cells remained low (7%). Haematopoietic cells, and specifically the mononuclear phagocyte system, gave rise to the majority of myofibroblasts found in occluded airways. Ablation of Cx3cR1

Identifiants

pubmed: 33033147
pii: 13993003.00344-2020
doi: 10.1183/13993003.00344-2020
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright ©ERS 2021.

Déclaration de conflit d'intérêts

Conflict of interest: M-P. Di Campli has nothing to disclose. Conflict of interest: A. Azouz has nothing to disclose. Conflict of interest: A. Assabban has nothing to disclose. Conflict of interest: J. Scaillet has nothing to disclose. Conflict of interest: M. Splittgerber has nothing to disclose. Conflict of interest: A. Van Keymeulen has nothing to disclose. Conflict of interest: F. Libert has nothing to disclose. Conflict of interest: M. Remmelink has nothing to disclose. Conflict of interest: A. Le Moine has nothing to disclose. Conflict of interest: P. Lemaitre has nothing to disclose. Conflict of interest: S. Goriely has nothing to disclose.

Auteurs

Maria-Pia Di Campli (MP)

Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.
ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.
Dept of Surgery, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Abdulkader Azouz (A)

Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.
ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Assiya Assabban (A)

Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.
ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Jessika Scaillet (J)

Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.
ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Marion Splittgerber (M)

Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.
ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Alexandra Van Keymeulen (A)

Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles, Brussels, Belgium.

Frederick Libert (F)

BRIGHTcore ULB VUB and Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium.

Myriam Remmelink (M)

Dept of Pathology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Alain Le Moine (A)

Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium.
ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Philippe Lemaitre (P)

Division of Thoracic Surgery, Lung Transplant Program, Columbia University Medical Center, New York, NY, USA.

Stanislas Goriely (S)

Institute for Medical Immunology, Université Libre de Bruxelles, Gosselies, Belgium stgoriel@ulb.ac.be.
ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles, Gosselies, Belgium.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH